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Cell-penetrating peptides, CPPs, are used as delivery vectors for pharmacologically interesting
substances, such as antisense oligonucleotides, proteins and peptides. We present a general
principle for designing cell-penetrating peptides derived from naturally occurring proteins as
well as from randomly generated polyamino acid sequences. Thereby, we introduce a novel
pharmacological principle for identiﬁcation of cell-penetrating peptides for which the
applications can be numerous, including cellular transduction vectors and mimics of
intracellular protein–protein interactions. The methods of identifying a CPP comprises
assessing the averaged bulk property values of the deﬁned sequence, and ensuring that they fall
within the bulk property value interval obtained from the training set. Despite this simplistic
approach, the search criteria proved useful for ﬁnding CPP properties in either proteins or
random sequences. We have experimentally veriﬁed cell-penetrating properties of 10–20-mer
peptides derived from naturally occurring proteins as well as from random poly-amino acids.
We note that since CPPs can be found in part of the protein sequences that may govern
protein interactions, it is possible to produce cell-penetrating protein agonists or antagonists.
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INTRODUCTION
During the last 10 years, several peptides have
been demonstrated to translocate across the plasma
membrane of eukaryotic cells by a seemingly energy-
independent or endocytotic pathway. These peptides
have been used for trans-membrane delivery of
hydrophilic macromolecules. Cellular delivery using
cell-penetrating peptides, CPPs, oﬀers several
advantages over conventional techniques as it is eﬃ-
cient for a range of cell types and can be applied to
cells en masse. Thus, CPPs might be used as delivery
vectors for pharmacologically interesting substances,
such as antisense oligonucleotides, proteins and
peptides. For reviews see (Lindgren et al., 2000;
Temsamani and Vidal 2004).
Little structural resemblance has been found
between the diﬀerent families of CPPs. However, as
all CPPs have a net positive charge, one can assume
that initially they should bind to negatively charged
head groups of lipids or proteins in the plasma
membrane. Here we present a method for ﬁnding
CPPs in proteins or random peptide sequences. In
many peptide quantitative structure activity rela-
tionship studies (QSAR), a set of dimensionless
variables is used to describe a composite of the
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physical characteristics of the amino acids. Sandberg
and colleagues published 5 such descriptor sets,
Z1–Z5; covering 87 coded and non-coded amino acids
(Sandberg et al., 1998).
Here, using the expanded descriptor scales, bulk
property values, (ZR/n), were assembled for 24 pub-
lished cell-penetrating peptides and 17 non-penetrat-
ing analogues (the training set); and averaged over
the total number of amino acids in the sequence.
Here, the Z3 value, mainly describing polarity, had
the highest predicting power. Using the criteria out-
lined by our approach, about 95% of the known CPP
sequences can be predicted.
Protein and random sequences where searched for
sequences falling within the bulk property value (ZS/
n) interval obtained from the training set. Using these
search criteria we selected and tested several novel




The averaged sums of various amino acid descriptors for
published CPPs (Table I) were assembled. In order to further re-
strict the descriptor intervals, the averaged descriptors of a range of
CPP analogues reported not to internalise (Table I) were used. As
further controls, non-related sequences of peptide hormones
(Table II) were used.
The most relevant descriptors from (Sandberg et al., 1998)
were Z1, Z2 and Z3. We found that the bulk of the amino acid side
chain, calculated as the number of heavy atoms (C, N, S and O) in
the side chains of the amino acids, and net donated hydrogen
bonds of the side chain, calculated as the accepted hydrogen bonds
of the side chains subtracted from the donated hydrogen bonds,
were necessary in order to predict CPPs. The value intervals with
the most predictive values are shown in Table III.
Peptide Synthesis
Peptides were synthesised in a stepwise manner in a 0.1 mmol
scale on a peptide synthesiser (Applied Biosystems model 431A,
USA) using t-Boc strategy of solid-phase peptide synthesis. tert-









































































+, Denotes sequence correctly predicted within the category; ),
denotes failed prediction.
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Butyloxycarbonyl amino acids (Neosystem, Strasbourg, France)
were coupled as hydroxybenzotriazole (HOBt) esters to a p-meth-
ylbenzylhydrylamine (MBHA) resin (Neosystem, Strasbourg,
France) to obtain C-terminally amidated peptide. Fluorescein-
carboxylic acid was coupled manually to the N-terminus by adding
a ﬁve-fold excess of HOBt and o-benzotriazole-1-yl-N, N, N¢, N¢-
tetramethyluronium tetraﬂuorborate (TBTU) activated ﬂuorescein
(Chemicon, Stockholm, Sweden) in DMF to the peptidyl-resin. The
peptide was ﬁnally cleaved from the resin with liquid HF at 0C for
30 min in the presence of p-cresol. The purity of the peptides was
>98% as demonstrated by HPLC on an analytical Nucleosil 120-3
C-18 RP-HPLC column (0.4 ( 10 cm) and the molecular mass was
obtained by using a MALDI-TOF mass-spectrometer (Voyager
DE-STR, Applied Biosystems, USA), and the calculated values
were obtained in each case.
Cell Culture
Mouse N2A and Human SHSY-5Y neuroblastoma cells were
grown in 10 cm Petri dishes in Dulbecco’s Modiﬁed Eagle’s Media
(DMEM) supplemented with 10% foetal calf serum (FCS), 2 mM
L-glutamine, 100 U/ml penicillin and 0.1 mg/ml streptomycin at
37C in a 5% CO2 atmosphere.
Bowes melanoma cells (American Type Culture Collection
CRL-9607) were cultivated in Minimal Essential Medium (MEM,
Life technologies, Stockholm, Sweden) with glutamax supple-
mented with 10% foetal bovine serum, penicillin–streptomycin,
non-essential amino acids and (1 mM) sodium pyruvate.
Cellular Internalisation Microscopy Assay
of Fluoresceinyl-Labelled Peptides
The cells used for internalisation assay were seeded out on
round glass coverslips in 24-well plates (approximately 60,000 cells/
well). One day post seeding, the cells were semi conﬂuent, and the
medium was changed to serum-free medium. The ﬂuorescein-la-
belled peptides were added, with a ﬁnal concentration of 5 lM.
After 60 min of incubation at 37C, the cells were washed 3 times
with 1 ml of Hepes–Krebbs–Ringer (HKR) buﬀer. The cell nuclei
were stained with Hoechst 33258 (0.5 lg/ml, Molecular Probes,
Holland). The ﬂuorescence was examined using UltraView ERS
confocal live cell imager (PerkinElmer Ltd., Upplands Va¨sby,
Sweden) connected to a Axiovert 200 (Zeiss, Go¨ttingen, Germany).
Quantitative Uptake
Human SH-SY5Y and mouse N2A neuroblastoma cells from
ATCC were cultured in DMEM supplemented with NEAA, so-
dium pyruvate and 10% FBS. Bowes human melanoma cells
(American Type Culture Collection CRL-9607) were cultured in
Eagle´s Minimal Essential Medium with Glutamax-I (Life Tech-
nologies, Gaithersburg, MD) supplemented with 10% foetal calf
serum, 1% non-essential amino acids, 1% sodium pyruvate, 100 (g/
ml streptomycin, 100 U/ml penicillin. 100,000 cells/ml/well were
seeded 2 days before experiments onto a 12-well-plate. The cells
were washed by 2 ( 1 ml HKR supplemented with 1 g/l glucose
(HKRg) then exposed to 300 ll of 5 or 20 lM peptide in HKRg at
37C for 30 min.
After the indicated time-points, the peptide treated cells were
washed and lightly trypsinated using 200 ll trypsin/EDTA (0.025%
T/E in HKR) at 37 degrees for 1 min and subsequently washed
thoroughly and lysed in 250 ll 0.1% Triton X-100 in HKR, at 4
degrees for 10 min. The cell lysates were transferred to a black plate
for ﬂuorescence readout at 492/520 nm. The samples were com-
pared to the ﬂuorescence of the added amount of peptide and
normalised against total protein amount.
Determination of Acute Membrane Disturbance
Lactate dehydrogenase leakage was measured as a determi-
nation of acute membrane disturbance. The sampling was done as a
multiplexing from assays performed under conditions as deﬁned
above. After indicated time and peptide or conjugate concentra-
tion, a 100 ll sample/well in triplicate were collected and detected
by CytoTox-ONE assay (Promega Corporation, Madison, WI)
according to manufactures instructions. The data is presented as a
percentage of the maximum leakage induced by treating the cells
with 0.1% Triton X-100 in HKR.
RESULTS
First we decided to search for CPP sequences in
G-protein coupled receptors. Three hundred and
seventy-nine human 7TM receptor sequences were
downloaded from the Swissprot database. The se-
quences were searched for CPPs of the indicated
length (8, 12 and 17 residues long). Here, a search
window size of 17 residues produced the most hits.
The 379 human 7TM receptor sequences contain
16,000 12-mer and 17,000 18-mer CPP sequences.
The position of the start of the CPP in the protein,
divided by the total length of the protein, is plotted
against the fraction of CPPs occurring at that
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position (see Fig. 1). The four peaks in evidence
correspond to the four intracellular parts of the 7TM
receptors, with the largest corresponding to the third
intracellular loop (IC3).
Many amino acid sequences, both, in naturally
occurring i.e., native proteins and computer-gener-
ated random amino acid sequences, contain cell-pe-
netrating peptides of diﬀerent length according to our
search. In 99 human transcription factor sequences
downloaded from Swissprot, 4500 12-mer and 4100
18-mers with CPP properties are predicted.
The surprising number of possible sequences is in
part due to clustering around short sequences that
function as ‘transport motors’. A similar behaviour
can be seen in searches in random generated se-
quences. Due to enormous volume of these data they
are not presented here. However, they are listed as a
part of a patent application (Ha¨llbrink et al., 2002).
Analysis of CPP search among the previously
reported cell-penetrating peptides yields controversial
results. Most of the reported CPPs fall into the CPP
class according to our search criteria. However, e.g.,
the tat peptide does not. Indeed, including the tat
peptides in the training set yields descriptor intervals
with little prediction power. Overall prediction suc-
cess (calculated as correctly predicted positive CPPs
subtracted by the percent of wrongly predicted neg-
ative CPPs) is 90%.
We experimentally veriﬁed the cell-penetrating
property of sequences derived from 7 diﬀerent
proteins: the GLP-1, AT1, D2(long), mGlu and gal-
anin receptors; the amyloid precursor protein and
presenilin-1 (Table IV). Fluorescence micrographs
showed that the peptides did indeed penetrate to the
cellular interior of human Bowes melanoma cells
(Fig. 2), indicating that the search criteria for cell-
penetrating peptides in naturally occurring proteins
have a predictive character.
We also searched random peptide sequences to
produce novel CPPs. As examples we present two 16-
residue sequences: E162 and E165 (Table IV).
In an attempt to compare the uptake eﬃciencies of
the CPPs, quantitative uptake measurements were
performed (Fig. 3). Here, the designed CPPs, E162
and E165 were by far the most eﬀective, reaching
intracellular concentrations approx 5–10 times that of
the positive control peptide penetratin. In contrast, the
peptides M448, M630 and M700 only reached con-
centrations approx 5 times less than the positive con-
trol. However, this corresponds to intracellular
concentrations that are above the extracellular con-
centration, thus indicating the diagnostic accumula-
tion seen for CPPs. Possibly, a partial explanation for
the varied uptake of the peptides could be diﬀerences
in degradation as been pointed out in (Ha¨llbrink et al.,
2004). In order to further characterise the uptake, the
time course of CPP internalisation into Bowes’ mela-
noma cells was investigated (Fig. 4a and b).
The membrane disturbance of the peptides was
investigated by examining the concentration and time









Fig. 1. Position of CPPs in human 7TM receptors. Human 7TM sequences were searched for CPPs of indicated length (8, 12 and 17 aa long).
The position of the CPP start in the protein was divided by the total length of the protein, plotted against the frequency of occurrence of CPPs
at that position. The four peaks in evidence correspond to the four intracellular parts of the 7TM receptors, with the largest peak corre-
sponding to the third internal loop (IC3). It can be noted that the CPP functionality seems to correlate well, both with the topology of the
7TM receptors, as well as with the proposed G-protein activation sites.
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dependence of LDH leakage from Bowes’ melanoma
cells (Fig. 5). Here, only 2 peptides, E162 and M511
caused leakage above baseline. This can be explained
by the comparatively high amphipatic moment of
these peptides.
DISCUSSION
Penetratin, or antennapedia (43–58), is a 16
amino acid long peptide corresponding to the third
helix of the Antennapedia homeodomain deprived of
its N-terminal glutamate (Derossi et al., 1996). The
peptide and analogues have been used for trans-
membrane delivery of a diversity of hydrophilic
macromolecules and has therefore been proposed to
be a universal intercellular delivery vector (Derossi
et al., 1998). Purely synthetic or chimeric peptides
have also been designed as reviewed in (Lindgren
et al., 2000).
Transportan, a non-natural peptide, is able to
deliver an antibody molecule with molecular mass of
about 150 kDa over the plasma membrane (Pooga
et al., 2001) although transportan itself is only a
3 kDa peptide. Transportan and penetratin were
demonstrated to deliver a non-natural DNA ana-
logue, PNA (peptide nucleic acid), into the cytoplasm
and nuclei of cells in culture as well as in vivo (Pooga
et al., 1998).
Another group of peptides, pepducines (Covic
et al., 2002; Kuliopulos and Covic 2003), derived
from G-protein coupled receptors, was designed by
attachment of a hydrophobic moiety to peptides de-
rived from the third intracellular loop of a receptor.
These peptides function as cell penetrating, full
agonist or antagonist of receptor G-protein signal-
ling. The pepducines are membrane-tethered chimeric
peptides and require the presence of their cognate
receptor for activity and are highly selective for the
receptor type.
Structurally, CPPs can be diﬀerentiated into 3
classes: the ﬁrst are peptides with low amphipa-
thicity where the charge contribution originates
mostly from arginine residues. Examples of this
class are penetratin and tat. The second class is
peptides with a high degree of amphipaticity, where
the charge contribution originates mainly from ly-
sine residues. Examples of this class are MAP and
transportan. In the third class the charged and
hydrophobic residues are separated lengthwise in
the chain, exempliﬁed by pVEC and MPG. There is
some evidence in the literature that these peptide
classes behave diﬀerently, especially concerning
endocytotic uptake.
Although their astonishing transport capability
has put CPPs in focus of scientiﬁc interest for the last
10 years, the mechanism(s) of translocation for the
diﬀerent CPPs are unknown. For instance, it is still
not known whether any particular secondary struc-
ture has to be induced in order to allow a translo-
cation, involving a concomitant transient membrane
destabilisation. It is clear, however, that the molecu-
lar details of the peptide–membrane interactions
must be of fundamental importance for the translo-
cation process. Both, a-helical and b-sheet structures
have been suggested as responsible for the CPP
properties; however, the exact mechanisms remain to
be proven.
The mechanism and requirements for internali-
sation have been studied on interactions between
Table IV. Protein-Derived Cell-Penetrating Peptides and Controls
Short name Protein Sequence
M 511 r/m AT1R(304–318) FLGKKFKKYFLQLLK-amide
G53-4 rGLP-1R 3rd intracellular loop analogue FLIFIRVICIVIAKLKANLMCKT-amide
APP521 hAPP(521–537) KKAAQIRSQVMTHLRVI-amide
M591 hD2R(213–228), long YIVLRRRRKRVNTKRS-amide




G55-9 r/m GluR1(864–882) 4th intracellular loop KLPCRSNTFLNIFRRKKPG-amide
M867 mGluR1 (691–706), rat 3rd intracellular loop KKICTRKPRFMSAWAQ-amide
– Penetratin RQIKIWFQNRRMKWKK
Abbreviations: R, receptor; r, rat; h, human; m, mouse.
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Fig. 2. Fluorescence microscopy ﬂuorescein labelled peptides. Fluorescence microscopy pictures of ﬂuorescein labelled peptides after incu-
bation in 5 lM for 30 min in 37C in live cells. The left column shows the confocal ﬂuorescence of the peptide, and the right column the
corresponding bright ﬁeld pictures. (a) Fluorescein labelled G55-9 in Bowes cells. (b) Fluorescein labelled E162 in Bowes cells. (c) Fluorescein
labelled M591 in Bowes cells. (d) Fluorescein labelled M593 in Bowes cells. (e) Fluorescein labelled App521 in Bowes cells. (f) Fluorescein
labelled M630 in Bowes cells. (g) Fluorescein labelled E165 in Bowes cells. (h) Fluorescein labelled G53-4 in Bowes cells. (i) Fluorescein
labelled M867 in Bowes cells. (j) Fluorescein labelled scr M511 in Bowes cells. (k) Fluorescein labelled M511 in Bowes cells. (l) Positive
control: Fluorescein labeled penetratin in Bowes cells.
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amphipathic a-helical peptides and lipid (bi)layers.
The results of these studies often suggest tryptophan
to be crucial for internalisation of peptides, but
although aromatic amino acids may be preferred in
CPP sequences, they are not absolutely necessary for
cell penetration.
The mechanism by which CPPs enter cells is not
clear. However, it has been proposed that CPPs can
be in equilibrium over the plasma membrane (Schel-
ler et al., 2000). Most studies on CPPs show that the
intracellular concentration of the labelled peptide is
signiﬁcantly higher than in the extracellular media.
Recently, we showed that the main mechanism by
which CPPs, or rather the cargo attached to the
CPPs, accumulate in the cellular interior is by the
proteolytic processing of the CPP-cargo conjugate
into membrane impermeable products (Ha¨llbrink
et al., 2004). Thus, CPP-cargo conjugates can be
viewed as a ‘pro-drug.’ Thus a CPP prediction
method should ideally take not only uptake, but also
processing of the peptide into account.
Recently, studies focusing on the CPP tat (48–60)
have pointed out that several published observations
concerning cell uptake may well be ﬂawed due to
methodological drawbacks, particularly in the case of
the tat peptide (Richard et al., 2003). These studies
have pointed out the importance of using methods
that avoid bias of measurements of uptake by plasma
membrane bound peptides. Thus when searching the
literature for CPPs sequences, care must be taken to
ensure that they have been evaluated on similar
grounds.
Futaki and colleagues have isolated CPPs from
proteins on the basis of charge (Futaki et al., 2001).
Speciﬁcally, Arg rich domains from RNA binding
proteins were isolated, in which a correlation with the
uptake eﬃciency and the number of Arg residues
were noted. Interestingly, peptides that contain less
than 5 Arg residues were much less active. However,
this method does not predict CPPs lacking suﬃcient
Arg residues, such as MAP or transportan.
Apart from the cell-penetration capability, little
correlation of structure or behaviour has been found
between CPPs. Until now, CPPs have thus not been
designed in a rational manner, but have been found
serendipitously. However, the sequences of CPPs
published so far have a positive net charge as a com-
mon feature, giving a starting point for the prediction
of CPP functionality in a given peptide sequence.
Clearly, though, all sequences with a positive net
charge cannot be cell penetrating, indicating that fur-
ther restrictions are needed to select CPPs with any
certainty.
Reasoning that the CPP property of the peptide is
a bulk property, i.e., that it depends not on speciﬁc
motives but rather on the net property of the amino
acid residues in the peptide, we assembled the aver-
aged sums of various amino acid descriptors for
published CPPs (Table II). In order to further res-











































Fig. 3. Quantitative uptake of ﬂuorescein labelled peptides. Human SH-SY5Y (ﬁlled bars) and mouse N2A neuroblastoma cells (empty bars)
were seeded 2 days before experiments onto a 12-well-plate and washed (2 ( 1 ml HKRg) then exposed at 300 ll of 5 lM peptide in HKRg at
37C for 30 min. The peptide treated cells were washed and lightly trypsinated and lysed in 0.1% Triton X-100 The cell lysates were examined
for ﬂuorescence readout at 492/520 nm. The samples were compared to the ﬂuorescence of the added amount of peptide and the total protein
amount.
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descriptors of a range of CPP analogues reported not
to internalise (Table II). As controls we used non-
related sequences of peptide hormones (Table III).
Despite this simplistic approach, the search criteria
proved surprisingly useful for ﬁnding CPP properties
in either proteins or random generated sequences.
Searching either a random- or natural protein
sequence, sequences corresponding to CPPs appear
clustered in blocks throughout the sequences. This
behaviour is due to the existence of ‘transport mo-
tors,’ i.e., shorter sequences with CPP characteristics,
in the search window. This has already been dem-
onstrated for several CPPs, e.g., penetratin (Fischer
et al., 2000) and transportan (Soomets et al., 2000),
using systematic deletions of the sequence. Here we
analyse the CPP search results for only a few classes
of natural proteins and random amino acid
sequences. In particular we were interested in
G-protein coupled receptors. If CPPs can be found in
part of the protein sequences that govern protein
interactions, it is possible to produce cell-penetrating
protein agonists or antagonists. Therefore we decided
to test potential CPPs derived from CGRP receptor
loop iC4, sequence 391–405 (M630); human D2
receptor long version, M591 and M593; mGlu
receptor, hGalR1.
From our data, it can be noted that the CPP
functionality seems to correlate well, both with the
topology of the 7TM receptors, as well as the pro-
posed G-protein activation sites. In a positional plot
for CPPs in 7TM receptors, four peaks appear
corresponding to the four intracellular parts of
the receptors. The largest peak coincides with the
position of the third intracellular loop (Fig. 1).
The internalisation experiments demonstrate
that APP (521–536), which is derived from the
extracellular part of the Alzheimer’s disease related
amyloid precursor protein (APP), has cell-penetrat-
ing abilities (Fig. 2), localising mainly in the cytosol
and plasma membrane. This could prove as a
putative pathway by which the secretory amyloid
precursor protein (sAPP) is internalised. This fact is
interesting since this fragment has been shown to
protect neurons against hypoglycemic damage and

























Fig. 4. Time course of CPP uptake in Bowe’s melanoma cells. Cells
were seeded 2 days before experiments onto a 12-well-plate and
washed (2 ( 1 ml HKRg) then exposed at 300 ll of 5 lM peptide in
HKRg at 37C for 30 min. The peptide treated cells were washed
and lightly trypsinated and lysed in 0.1% Triton X-100 The cell
lysates were examined for ﬂuorescence readout at 492/520 nm. The
samples were compared to the ﬂuorescence of the added amount of
peptide and the total protein amount. (a) Peptides internalising
using an apparent ﬁrst order kinetic type. Filled box – E162; empty
triangle – E165; empty box – M591; ﬁlled triangle – G55-9. (b)
Peptides internalizing not using an apparent ﬁrst order kinetic type.
Filled box – G53-4; empty triangle – M867; empty box – M630;
ﬁlled triangle – penetratin; Filled circle – APP521; empty circle –
M593.













Fig. 5. The membrane disturbance of the peptides was investigated
by examining the concentration and time dependence of LDH
leakage from Bowe’s melanoma cells. Only M511 (ﬁlled boxes) and
E162 (empty boxes) caused leakage above baseline. The data is
presented as a percentage of the maximum leakage induced by
treating the cells with 0.1% Triton X-100 in HKR.
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glutamate neurotoxicity thus acting as neuropro-
tective agent.
The time course of uptake of the new CPPs
indicate that the kinetic proﬁle of the peptides fall
within 2 diﬀerent groups. One, in which the peptides
seem to follow ﬁrst order (equilibrium) kinetics
(Fig. 4a). The second, where the intracellular ﬂuo-
rescence quickly reaches a maximum, followed by a
steady decrease in signal (Fig. 4b). These diﬀerent
behaviours can be attributed to diﬀerent degrada-
tion propensities of the peptides, both inside and
outside the cell. However, the main scope of this
paper is not to dissect the various pathways leading
to the CPP phenomenon and work to fully cha-
racterise the transport and degradation pathways
are under way.
Interestingly, only 2 of the examined peptides
caused any measurable plasma membrane distur-
bance (Fig. 5). This indicates that there must exist a
large number of useful, non-toxic, CPPs still to be
characterised.
Taken together, the uptake and leakage data
suggest that several of the peptides examined in this
work would be suitable for intracellular delivery of
pharmacologically interesting substances. The most
interesting peptide, from a practical point-of-view, is
the designed E165, which have the highest delivery
capacity coupled with negligible plasma membrane
toxicity.
In conclusion, we present a simple method for
CPP prediction based on bulk properties of the
constituent amino acids. It is likely that the mecha-
nism of CPP uptake is somewhat complicated to ex-
plain with the bulk properties of the constituents
only, in particular concerning peptide degradation.
However, this method of CPP prediction can be
successfully applied to ﬁnd novel CPPs, as well as the
peptides with non-CPP properties. Peptides contain-
ing an active CPP fused to a translocation inhibitory
domain via a protease sensitive motif, can be used to
deliver cargo selectively in vivo (Ha¨llbrink et al., 2002;
Jiang et al., 2004). This approach can be applied for
design of diﬀerent drug precursors for medical
applications in future.
We hypothesise that the natural protein derived
CPP sequences may characterise some functionality
of proteins perhaps in the cellular distribution, fold-
ing or shuttling, similar to the tat and antennapedia
proteins. This tempting hypothesis, however, remains
to be proven.
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